Sarah McWhirter, PhD

Sarah McWhirter, PhD 

Vice President and Head of Biology, Lycia Therapeutics

smcwhirter[at]aduro.com

Sarah McWhirter serves as Vice President and Head of Biology at Lycia Therapeutics.  Dr. McWhirter has more than 20 years of combined experience in biochemistry, immunology and oncology in both academic and industrial settings. She earned her Ph.D. in Molecular and Cell Biology at University of California, Berkeley in the laboratory of Dr. Tom Alber.  She performed postdoctoral work at Harvard University in the laboratory of Dr. Tom Maniatis studying novel host innate immune signaling pathways.  Over the last several years she has focused her efforts on developing novel therapeutics to treat cancer, autoimmune disorders and infectious diseases.  Sarah is currently leads both the research and translational medicine teams to support early clinical development efforts at Lycia Therapeutics.